Final Diagnosis -- IgD/Lambda Multiple Myeloma with Plasma Cell Leukemia





  1. Blade J. et al; Nonsecretory myeloma, IgD myeloma, and plasma cell leukemia; Hematology-Oncology Clinics of North America. 13(6):1259-72/1999 Dec.
  2. Weinlander G. et al; Cytogenetic analysis and FISH in a case of IgD MM; Cancer Genitics and Cytogenetics. 105(2):172-6, 1998 Sep.
  3. Shimamoto Y. et al; A new risk for grouping for IgD myeloma based on analysis of 165 Japanese patients; European Journal of Hematology. 47(4):262-7, 1991 Oct.
  4. Blade J. et al; IgD MM: Presenting features, response to therapy, and survival in a series of 53 cases; Journal of Clinical Oncology.12(11):2398-404, 1994 Nov.
  5. Le Quellec A et al; IgD MM. A retrospective study in the Languedoc region; Press Medicale. 18(22):1110-3, 1989 Jun 3.
  6. Tichy M. et al; IgD paraproteinemias; Neoplasea.40(1):59-61, 1993.
  7. O'Connor ML et al; Immunoglobulin D benign monoclonal gammopathy. A case report; Cancer. 68(3):611-6, 1991 Aug 1.
  8. Delannoy A; Amylase-producing IgD-type multiple myeloma. [Review] [8 refs] Journal of Internal Medicine. 232(5):457-60, 1992 Nov.
  9. Nakajima T.; Neuron specific enolase-producing IgD multiple myeloma with high serum amylase activity Rinsho Ketsueki - Japanese Journal of Clinical Hematology. 36(4):359-64, 1995 Apr.

Contributed by Hazim Najjar, MB, BS, MD


IndexCME Case StudiesFeedbackHome